Login to Your Account

Karo Bio raising $13M as it steps back to preclinical research

By Cormac Sheridan
Staff Writer

Thursday, February 13, 2014
Shares in Karo Bio AB dropped 13 percent Thursday on news that the company was raising SEK84.7 million (US$13.1 million) in a heavily discounted share issue. The offering is priced at SEK0.47 per share, a hefty markdown on Wednesday’s closing share price of SEK0.72.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription